Nutriband Closes $8.4M Private Placement for Commercial Development of Aversa(R) Fentanyl Transdermal Patch Through FDA Submission

Private Placement of $8.4 million has closed and will fund the commercial development of lead product AVERSA Fentanyl to NDA filingNutriband working to complete the commercial scale-up prior to performing the pivotal laboratory assessment and …
Jetzt den vollständigen Artikel lesen